Results 281 to 290 of about 5,994,707 (387)

Targeting P2X Receptors-Current Progress in Sepsis. [PDF]

Int J Inflam
Luo L, Zhao Q, Tian Y, Sun M, Zhang M, Wang B.   +5 more
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Translational Insights into NK Immunophenotyping: Comparative Surface Marker Analysis and Circulating Immune Cell Profiling in Cancer Immunotherapy. [PDF]

Int J Mol Sci
Tsyplenkov KK, Belousova AA, Zinovyeva MV, Alekseenko IV, Pleshkan VV.   +4 more
europepmc   +1 more source

Insulin-Receptor Interaction in Isolated Fat Cells

, 1969
Tomomi Minemura, Oscar B. Crofford
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Characterization of the low-density lipoprotein receptors family and identification of vitellogenin receptors in Mugil cephalus. [PDF]

Sci Rep
Miccoli A, Randazzo B.
europepmc   +1 more source

The Cholinergic Receptor

Journal of Pharmacy and Pharmacology, 1960
openaire   +4 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Interaction Between Oxytocin and Dopamine Signaling: Focus on the Striatum. [PDF]

Int J Mol Sci
Guidolin D, Tortorella C, Cervetto C, Marcoli M, Maura G, Agnati LF.   +5 more
europepmc   +1 more source

SELECTIVE ADRENERGIC BETA-RECEPTOR BLOCKADE IN THE PREVENTION OF ADRENALINE-EVOKED VENTRICULAR ARRHYTHMIAS IN DOGS ANAESTHETIZED WITH HALOTHANE IN OXYGEN

, 1969
Poonam Sharma
openalex   +1 more source